Skip to main content
. Author manuscript; available in PMC: 2013 Feb 15.
Published in final edited form as: J Immunol. 2009 Jan 1;182(1):675–683. doi: 10.4049/jimmunol.182.1.675

Figure 7.

Figure 7

Tolerance to DNFB following HSP antibody treatment is antigen specific. C3H/HeN mice were treated with HSP antibody on the abdomen after which 0.5% DNFB was applied to the same site. After 14 days, the mice were resensitized on the shaved back with either 0.5%DNFB or 3% oxazolone. Mice were ear challenged 5 days later with the same hapten that had been applied the back. Ear swelling responses indicate that the inhibition of CHS response produced by the HSP antibody was present in the DNFB back sensitized group (*p<0.05), but was not present in the oxazalone back sensitized mice (p>0.05). Results were expressed as change in auricular thickness ± SEM. There were four mice per group and each experiment was repeated twice with identical results. The data shown are from a representative experiment.